Title:
COMPOSITION USED TO PREVENT OR SUPPRESS REFEEDING SYNDROME
Document Type and Number:
WIPO Patent Application WO/2023/068297
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing a composition that is used in order to prevent or suppress refeeding syndrome. Provided as a solution to the problem is a composition that is used to prevent or suppress refeeding syndrome, the composition containing an mTOR inhibitor.
Inventors:
YAMAOKA IPPEI (JP)
Application Number:
PCT/JP2022/038927
Publication Date:
April 27, 2023
Filing Date:
October 19, 2022
Export Citation:
Assignee:
OTSUKA PHARMA FACTORY INC (JP)
International Classes:
A23L33/10; A61K31/439; A61K45/00; A61P3/00; A61P43/00
Foreign References:
| JP2019513727A | 2019-05-30 |
Other References:
KOUMAKIS EUGéNIE; CORMIER CATHERINE; ROUX CHRISTIAN; BRIOT KARINE: "The Causes of Hypo- and Hyperphosphatemia in Humans", CALCIFIED TISSUE INTERNATIONAL, NEW YORK, NY, US, vol. 108, no. 1, 13 April 2020 (2020-04-13), US , pages 41 - 73, XP037328564, ISSN: 0171-967X, DOI: 10.1007/s00223-020-00664-9
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: